Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment

NCT00980460 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00980460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00980460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2009
Completion date
March 31, 2026
Enrollment
236 (actual)
Sites
209

Conditions

As the registry lists them; a condition with its own page is linked.

pretext i hepatoblastoma, pretext ii hepatoblastoma, pretext iii hepatoblastoma, pretext iv hepatoblastoma